The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
Tarih
2010Yazar
DEPRESSEUX, G.
Guel, Ahmet
CATTANEO, R.
FONT, J.
COSYNS, J-P
CERVERA, R.
HOUSSIAU, F. A.
VASCONCELOS, C.
D'CRUZ, D.
BLOCKMANS, D.
SEBASTIANI, G. D.
DE RAMON GARRIDO, E.
DANIELI, M. G.
Abramovicz, D.
CAULI, A.
Direskeneli, H.
GALEAZZI, M.
LEVY, Y.
PETERA, P.
POPOVIC, R.
PETROVIC, R.
SINICO, R. A.
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) cyclophosphamide (CY) followed by azathioprine (AZA) as treatment for proliferative lupus nephritis.
Koleksiyonlar
- Makale [92796]